Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Immunocellular Thera (IMUC)

0.2297 -0.043 (-15.83%)

12-11 15:59

Open:

0.279

Pre. Close:

0.2729

High:

0.279

Low:

0.17

Volume:

3,533,201

Market Cap:

5M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.29 - 0.29

0.29 - 0.3

Low:

0.16 - 0.16

0.16 - 0.17

Close:

0.22 - 0.23

0.23 - 0.24

Technical analysis  (as of: 2017-12-11 4:48:27 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 0.34     One year: 0.42

Support:

Support1: 0.17    Support2: 0.14

Resistance:

Resistance1: 0.29    Resistance2: 0.36

Pivot:

0.30

Moving Averages:

MA(5): 0.27     MA(20): 0.31

MA(100): 0.34     MA(250): 1.36

MACD:

MACD(12,26): -0.02     Signal(12,26,9): -0.02

%K %D:

%K(14,3): 15.22     %D(3): 12.42

RSI:

RSI(14): 23.35

52-Week:

High: 4.27  Low: 0.17  Change(%): -90.1

Average Vol(K):

3-Month: 253347  10-Days 187118

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
IMUC has closed below the lower band by 15.6%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for IMUC is to continue within current trading range. It is unclear right now based on current numbers. 56.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to IMUC's normal range. The bands have been in this narrow range for 88 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 15 May 2017 20:03:45 GMT
ImmunoCellular Therapeutics Announces First Quarter 2017 Financial Results

Wed, 23 Aug 2017 20:03:45 GMT
ImmunoCellular Therapeutics Provides Business Update on Research and ...

Tue, 18 Jul 2017 14:15:00 GMT
Immunocellular prices equity offering; shares down 48%

Tue, 12 Dec 2017 11:48:38 GMT
Notable Stock's Buzzers: ImmunoCellular Therapeutics, Ltd., (NYSE: IMUC), KKR ...

Tue, 12 Dec 2017 11:15:00 GMT
The technical Chart For ImmunoCellular Therapeutics, Ltd. (IMUC), Etsy, Inc ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

23.79

Shares Float (M)

34.85

% Held by Insiders

0.98

% Held by Institutions

3.84

Shares Short (K)

1710

Shares Short Prior Month (K)

1680

Stock Financials

EPS

-3.427

EPS Est. Current Year

-3.830

EPS Est. Next Year

-0.640

EPS Est. Next Quarter

Forward EPS

-0.635

Book Value (p.s.)

-0.020

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-107.7

Return on Equity (ttm)

-363.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.048

Qtrly Earnings Growth

Operating Cash Flow (M)

-15.48

Levered Free Cash Flow (M)

-8.94

atoplab.com

Valuation

P/E

-0.07

P/E Growth Ratio

-0.15

P/BV

-11.49

P/S

P/CF

-0.35

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-11-21

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.